Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

Antipsychotic drug use in pregnancy: A multinational study from ten countries

(2020) Johan Reutfors et al.   SCHIZOPHRENIA RESEARCH

Adjusting for unmeasured confounding using validation data: Simplified two-stage calibration for survival and dichotomous outcomes

(2019) Vidar Hjellvik et al.   STATISTICS IN MEDICINE

Maternal schizophrenia and adverse birth outcomes: what mediates the risk?

(2019) Simone N. Vigod et al.   SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY

Genetics of attention deficit hyperactivity disorder

(2018) Stephen V. Faraone et al.   MOLECULAR PSYCHIATRY

The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004–2015

(2017) Pål Gjerden et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study

(2017) C-M Cheng et al.   MOLECULAR PSYCHIATRY

Antidepressants, Antipsychotics, and Mood Stabilizers in Pregnancy: What Do We Know and How Should We Treat Pregnant Women with Depression

(2017) Asher Ornoy et al.   Birth Defects Research

Neurodevelopmental outcomes in infants exposed in utero to antipsychotics: a systematic review of published data

(2016) Salvatore Gentile et al.   CNS SPECTRUMS

The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis

(2016) Malcolm J Price et al.   HEALTH TECHNOLOGY ASSESSMENT

Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

(2016) Krista F. Huybrechts et al.   JAMA Psychiatry

Obstetric and Neonatal Outcomes After Antipsychotic Medication Exposure in Pregnancy

(2015) Catherine G. Coughlin et al.   OBSTETRICS AND GYNECOLOGY

Preterm Birth and Poor Fetal Growth as Risk Factors of Attention-Deficit/Hyperactivity Disorder

(2015) M. Sucksdorff et al.   PEDIATRICS

Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study

(2015) S. N. Vigod et al.   BMJ-British Medical Journal

Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study

(2015) S. N. Vigod et al.   BMJ-British Medical Journal

Ethical aspects of registry-based research in the Nordic countries

(2015) Jonas Ludvigsson et al.   Clinical Epidemiology

Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine

(2015) Ljubica Vucicevic et al.   Autophagy

Mediators of the association between parental severe mental illness and offspring neurodevelopmental problems

(2014) Brittany M. McCoy et al.   ANNALS OF EPIDEMIOLOGY

The increasing prevalence of reported diagnoses of childhood psychiatric disorders: a descriptive multinational comparison

(2014) Hjördis O. Atladottir et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Family History of Schizophrenia and Bipolar Disorder as Risk Factors for Autism

(2012) Patrick F. Sullivan et al.   ARCHIVES OF GENERAL PSYCHIATRY

Autism Spectrum Disorder, ADHD, Epilepsy, and Cerebral Palsy in Norwegian Children

(2012) P. Suren et al.   PEDIATRICS

Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study

(2012) R. Boden et al.   BMJ-British Medical Journal

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

(2011) G. C. Alexander et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Brief report: validity of Finnish registry-based diagnoses of autism with the ADI-R

(2010) KM Lampi et al.   ACTA PAEDIATRICA

The Nordic Countries as a Cohort for Pharmacoepidemiological Research

(2009) Kari Furu et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY